RMD Q3 2021 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q3 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$769M-0.1% YoY

Gross Profit

$447M58.2% margin

Operating Income

$223M29.1% margin

Net Income

-$78M-10.2% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

$196M

Free Cash Flow

$167M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$4.6B

Total Liabilities

$1.9B

Stockholders' Equity

$2.7B

Cash & Equivalents

$231M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$769M	$769M	-0.1%
Gross Profit	$447M	$450M	-0.5%
Operating Income	$223M	$218M	+2.7%
Net Income	-$78M	$163M	-148.1%

Revenue Segments

Devices And Masks

$675M88%

Software As Service

$94M12%

Geographic Segments

Us Canada And Latin America

$497M65%

Combined Europe Asia And Other Markets

$272M35%